1. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsDonor Selection -- standardsHepacivirusHepatitis C -- bloodHIV Infections -- bloodHIV-1RNA, Viral -- bloodBlood -- virologyBlood TransfusionDisease Transmission, Infectious -- prevention & controlNucleic Acid Amplification TechniquesPolymerase Chain ReactionHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Recommendations for reducing the risk of transfusion-transmitted babesiosis Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2019 Subject(s): Babesiosis -- transmissionBlood TransfusionDisease Transmission, Infectious -- prevention & controlDonor Selection -- standardsBabesiosis -- prevention & controlBlood -- microbiologySurveys and QuestionnairesHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023 Subject(s): Blood Banking -- standardsBlood Donation -- standardsBlood DonorsDonor Selection -- standardsGovernment RegulationGuideline AdherencePlasmaUnited States
